This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
What the researchers found
BPC 157 exhibits strong cytoprotective and healing properties in the gastrointestinal tract and demonstrates neuroprotective effects in multiple central nervous system injury models. It modulates serotonergic and dopaminergic neurotransmission and promotes nerve regeneration and functional recovery in animal studies.
Why it matters
BPC 157’s dual action on gut and brain health highlights its potential as a novel therapeutic agent for complex disorders involving both systems, which are often difficult to treat effectively.
How the study worked
This article is a review summarizing experimental research on BPC 157’s effects on the brain-gut axis, including animal models of gastrointestinal lesions, nerve injury, and central nervous system disorders.
What this study cannot tell us
The findings are primarily based on animal studies and preclinical models; clinical efficacy and safety in humans require further investigation.
Read the original research
Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications.
Current neuropharmacology, 14(8), 857-865
Citation
Sikiric, Predrag; Seiwerth, Sven; Rucman, Rudolf; Kolenc, Danijela; Vuletic, Lovorka Batelja; Drmic, Domagoj; Grgic, Tihomir; Strbe, Sanja; Zukanovic, Goran; Crvenkovic, Dalibor; Madzarac, Goran; Rukavina, Iva; Sucic, Mario; Baric, Marko; Starcevic, Neven; Krstonijevic, Zoran; Bencic, Martina Lovric; Filipcic, Igor; Rokotov, Dinko Stancic; Vlainic, Josipa. (2016). Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications.. Current neuropharmacology, 14(8), 857-865.